CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Curon Medical, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Curon Medical, Inc.
46117 Landing Parkway
Phone: (510) 661-1800p:510 661-1800 FREMONT, CA  94538  United States Fax: (302) 655-5049f:302 655-5049

This company is no longer actively traded on any major stock exchange.

Business Summary
Curon Medical, Inc., formerly known as Conway-Stuart Medical, Inc., develops, manufactures and markets products for the treatment of gastrointestinal disorders. The Company's products consist of radiofrequency generators and single-use disposable devices. Curon's first product, the Stretta System, is designed for the treatment of gastroesophageal reflux disease (GERD). Its second product, the Secca System, is a radiofrequency energy-based system for the treatment of bowel incontinence (formerly and clinically referred to as fecal incontinence). The Stretta System consists of a disposable catheter with needle electrodes and Curon's control module, which is a radiofrequency energy generator. Using the Secca System, physicians deliver radiofrequency energy to the sphincter muscle in the anal canal. The Company markets the Stretta System to high volume general surgeons and gastroenterologists. Curon markets the Secca System primarily to colon and rectal surgeons and to those general surgeons who perform colorectal surgery.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/200612/31/2005YesYesYes-Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chief Executive Officer, President Larry C.Heaton 49 11/13/2006 1/2/2003
Chief Financial Officer, Vice President of Finance and Administration Alistair F.McLaren 65 3/1/1998 3/1/1998
Executive Vice President of Sales & Marketing, President of International and Chief Sales & Marketi CarlosBabini 57 4/1/2004 10/1/2003

Business Names
Business Name
Conway-Stuart Medical, Inc.
CRNM
Curon Medical BVBA

General Information
Outstanding Shares: 10,837,733 (As of 7/28/2006)
Shareholders: 1,600
Stock Exchange: OTC
Federal Tax Id: 770470324
Fax Number: (302) 655-5049
Email Address: investor@curonmedical.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023